<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04354220</url>
  </required_header>
  <id_info>
    <org_study_id>KISPI-CAPNO</org_study_id>
    <nct_id>NCT04354220</nct_id>
  </id_info>
  <brief_title>Capnography Monitoring in Ventilated Children</brief_title>
  <official_title>Accuracy of Capnography Monitoring in Invasively and Non-invasively Ventilated Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vincenzo Cannizzaro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Children's Hospital, Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      End-tidal CO2 measurements in children will be assessed for their accuracy with arterial CO2
      measurements.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      End-tidal and arterial CO2 measurements will be performed in invasively and non-invasively
      ventilated critically ill children. The endtidal CO2 values will assessed for their accuracy
      with respect to different underlying diseases and conditions of the children.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 9, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of end-tidal Carbon Dioxide (PetCO2) values in comparison to arterial Carbon Dioxide (PaCO2) values in invasively and non-invasively ventilated critically ill children without lung or heart disease</measure>
    <time_frame>On average every participant will be assessed for 5 days</time_frame>
    <description>Mean absolute measurement difference between simultaneously obtained PaCO2 and PetCO2 values (bias) and their 95% limits of agreement (precision) in children and newborns without cardiopulmonary dysfunction. Units of measure will be in kilopascal (kPa) for PetCO2 and PaCO2, respectively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Accuracy of end-tidal Carbon Dioxide (PetCO2) values in comparison to arterial Carbon Dioxide (PaCO2) values in invasively and non-invasively ventilated critically ill children with lung and or heart disease</measure>
    <time_frame>On average every participant will be assessed for 5 days</time_frame>
    <description>Cardiopulmonary function-dependent mean absolute measurement difference between simultaneously obtained PaCO2 and PetCO2 values (bias) and their 95% limits of agreement (precision) in children and newborns with cardiopulmonary dysfunction. Units of measure will be in kilopascal (kPa) for PetCO2 and PaCO2, respectively.</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">770</enrollment>
  <condition>Child, Only</condition>
  <condition>Infant, Newborn, Diseases</condition>
  <condition>Critical Illness</condition>
  <condition>ARDS, Human</condition>
  <condition>Heart Defects, Congenital</condition>
  <condition>Lung Diseases, Obstructive</condition>
  <condition>Lung Diseases, Interstitial</condition>
  <arm_group>
    <arm_group_label>no shunt, no lung injury</arm_group_label>
    <description>ventilated newborns / infants / children with healthy lungs and without or corrected congenital heart disease and no intra-/extra-cardiac shunt</description>
  </arm_group>
  <arm_group>
    <arm_group_label>mild lung injury</arm_group_label>
    <description>ventilated newborns / infants / children with mild lung injury (OI between 4 and 8)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>moderate-severe lung injury</arm_group_label>
    <description>ventilated newborns / infants / children with moderate or severe lung injury (OI above 8)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>shunt lesion</arm_group_label>
    <description>ventilated newborns / infants / children with cyanotic heart diseases and therefore existing intra-cardiac or extra- cardiac right-left shunt lesions</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>capnography monitoring</intervention_name>
    <description>routinely used capnography monitoring</description>
    <arm_group_label>mild lung injury</arm_group_label>
    <arm_group_label>moderate-severe lung injury</arm_group_label>
    <arm_group_label>no shunt, no lung injury</arm_group_label>
    <arm_group_label>shunt lesion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>arterial blood gas</intervention_name>
    <description>Routinely taken arterial blood gas values</description>
    <arm_group_label>mild lung injury</arm_group_label>
    <arm_group_label>moderate-severe lung injury</arm_group_label>
    <arm_group_label>no shunt, no lung injury</arm_group_label>
    <arm_group_label>shunt lesion</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Critically ill infants and children under invasive and non-invasive mechanical ventilation,
        regardless of their underlying acute or chronic diseases, as long as an arterial line for
        blood gas analyses is in situ.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children on pressure controlled mechanical invasive or non-invasive ventilation on the
             Paediatric Intensive Care Unit of the University Children's Hospital Zurich

          -  Newborns with a birthweight of at least 2.0 kg

          -  Newborns with an age of at least 1 hour (age &gt; 60 minutes)

          -  Children up to the last day of the 13th year of living

          -  Ability of care taker or patient to understand verbal and written instructions and the
             general consent or informed consent in German or English

          -  Obtained written general or informed consent as documented by signature

          -  Available arterial line, i.e. a specific catheter inserted in an artery

        Exclusion Criteria:

          -  Care taker or participant unable for linguistic, mental or other reasons or unwilling
             to understand verbal or written information and to give written informed consent in
             German or English

          -  Care taker not available

          -  Newborns with a birthweight below 2.0 kg

          -  Newborns younger than 1 hour (age &lt;60 minutes)

          -  Children with an age of 14 years onwards

          -  Missing arterial line

          -  Patients dependent on any other kind of respiratory support that is not compatible
             with the PcCO2-sensor or where a high leakage in the respiratory circuit makes PcCO2
             measurements impossible (nasal mask ventilation, low-flow-/high-flow-ventilation,
             rebreathing mask, high- frequency-oscillation)

          -  Patients where the investigators act on the assumption that mechanical ventilation
             will be discontinued and/or the arterial line will be removed within 6 hours or where
             only one pair of values (arterial and endtidal CO2) can be compared

          -  Patients with a cyanotic shunt lesion with a weight of 15 kg or above
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>13 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Florian Zapf, MD</last_name>
    <phone>+41775108932</phone>
    <email>florian.zapf@kispi.uzh.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vincenzo Cannizzaro, MD, PhD</last_name>
    <phone>+41442667111</phone>
    <email>vincenzo.cannizzaro@kispi.uzh.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Children's Hospital</name>
      <address>
        <city>Zurich</city>
        <zip>8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincenzo Cannizzaro, MD, PhD</last_name>
      <phone>+41442667111</phone>
      <email>vincenzo.cannizzaro@kispi.uzh.ch</email>
    </contact>
    <investigator>
      <last_name>Florian Zapf, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dimitris Siabalis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philipp Baumann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adam Roggia, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernhard Voss, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 16, 2019</study_first_submitted>
  <study_first_submitted_qc>April 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2020</study_first_posted>
  <last_update_submitted>June 11, 2020</last_update_submitted>
  <last_update_submitted_qc>June 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Children's Hospital, Zurich</investigator_affiliation>
    <investigator_full_name>Vincenzo Cannizzaro</investigator_full_name>
    <investigator_title>Senior consultant and head of research</investigator_title>
  </responsible_party>
  <keyword>capnography</keyword>
  <keyword>end-tidal CO2</keyword>
  <keyword>critically ill children</keyword>
  <keyword>ventilated</keyword>
  <keyword>accuracy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Infant, Newborn, Diseases</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

